Moleculin Biotech has reported preliminary blinded data from Part A of its ongoing pivotal Phase II/III MIRACLE trial assessing AnnAraC in adult patients with r/r AML.

The post Moleculin reports interim results from MIRACLE trial in r/r AML patients appeared first on Clinical Trials Arena.